Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms

Low-dose AtropIne for Myopia Control in Children (AIM): protocol for a randomised, controlled, double-blind, multicentre, clinical trial with two parallel arms

Introduction Myopia is a major cause of degenerative eye disease and increases the risk of secondary visual impairment. Mitigating its progression therefore has great potential of clinically relevant benefit as shown by using highly diluted atropine eye drops in children of Asian origin. However, li...

Full description

Bibliographic Details
Main Authors: Armin Wolf, Daniel Böhringer, Sebastian Küchlin, Focke Ziemssen, Wolf A Lagrèze, Stefanie Schmickler, Anja Eckstein, Philipp Eberwein, Gabriele Ihorst, Frank Schuettauf, Navid Farassat, Fanni E Molnár, Anne Schwietering, Dorina Seger, Martin J Hug, Anja-Birte Knöbel, Sabine Schneider-Fuchs, Bettina Wabbels, Christina Beisse, Andrea Hedergott, Theresia Ring-Mangold, Claudia Schuart, Julia Biermann, Karsten Hufendiek, Gabriele Gusek-Schneider, Michael Schittkowski, Thomas Lischka
Format: Article
Language:English
Published: BMJ Publishing Group 2023-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/4/e068822.full

Internet

https://bmjopen.bmj.com/content/13/4/e068822.full

Similar Items